Literature DB >> 21252236

NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1.

Ekaterina N Lyukmanova1, Zakhar O Shenkarev, Mikhail A Shulepko, Konstantin S Mineev, Dieter D'Hoedt, Igor E Kasheverov, Sergey Yu Filkin, Alexandra P Krivolapova, Helena Janickova, Vladimir Dolezal, Dmitry A Dolgikh, Alexander S Arseniev, Daniel Bertrand, Victor I Tsetlin, Mikhail P Kirpichnikov.   

Abstract

Discovery of proteins expressed in the central nervous system sharing the three-finger structure with snake α-neurotoxins provoked much interest to their role in brain functions. Prototoxin LYNX1, having homology both to Ly6 proteins and three-finger neurotoxins, is the first identified member of this family membrane-tethered by a GPI anchor, which considerably complicates in vitro studies. We report for the first time the NMR spatial structure for the water-soluble domain of human LYNX1 lacking a GPI anchor (ws-LYNX1) and its concentration-dependent activity on nicotinic acetylcholine receptors (nAChRs). At 5-30 μM, ws-LYNX1 competed with (125)I-α-bungarotoxin for binding to the acetylcholine-binding proteins (AChBPs) and to Torpedo nAChR. Exposure of Xenopus oocytes expressing α7 nAChRs to 1 μM ws-LYNX1 enhanced the response to acetylcholine, but no effect was detected on α4β2 and α3β2 nAChRs. Increasing ws-LYNX1 concentration to 10 μM caused a modest inhibition of these three nAChR subtypes. A common feature for ws-LYNX1 and LYNX1 is a decrease of nAChR sensitivity to high concentrations of acetylcholine. NMR and functional analysis both demonstrate that ws-LYNX1 is an appropriate model to shed light on the mechanism of LYNX1 action. Computer modeling, based on ws-LYNX1 NMR structure and AChBP x-ray structure, revealed a possible mode of ws-LYNX1 binding.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252236      PMCID: PMC3060513          DOI: 10.1074/jbc.M110.189100

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Molecular determinants by which a long chain toxin from snake venom interacts with the neuronal alpha 7-nicotinic acetylcholine receptor.

Authors:  S Antil-Delbeke; C Gaillard; T Tamiya; P J Corringer; J P Changeux; D Servent; A Ménez
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

2.  Candoxin, a novel toxin from Bungarus candidus, is a reversible antagonist of muscle (alphabetagammadelta ) but a poorly reversible antagonist of neuronal alpha 7 nicotinic acetylcholine receptors.

Authors:  Selvanayagam Nirthanan; Eric Charpantier; Ponnampalam Gopalakrishnakone; Matthew C E Gwee; Hoon-Eng Khoo; Li-Sam Cheah; Daniel Bertrand; R Manjunatha Kini
Journal:  J Biol Chem       Date:  2002-03-07       Impact factor: 5.157

3.  Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1.

Authors:  Inés Ibañez-Tallon; Julie M Miwa; Hai Long Wang; Niels C Adams; Gregg W Crabtree; Steven M Sine; Nathaniel Heintz
Journal:  Neuron       Date:  2002-03-14       Impact factor: 17.173

4.  Measurement of homonuclear proton couplings from regular 2D COSY spectra.

Authors:  F Delaglio; Z Wu; A Bax
Journal:  J Magn Reson       Date:  2001-04       Impact factor: 2.229

Review 5.  Snake and snail toxins acting on nicotinic acetylcholine receptors: fundamental aspects and medical applications.

Authors:  V I Tsetlin; F Hucho
Journal:  FEBS Lett       Date:  2004-01-16       Impact factor: 4.124

Review 6.  Three-finger alpha-neurotoxins and the nicotinic acetylcholine receptor, forty years on.

Authors:  Selvanayagam Nirthanan; Matthew C E Gwee
Journal:  J Pharmacol Sci       Date:  2004-01       Impact factor: 3.337

7.  Alpha-conotoxins ImI and ImII. Similar alpha 7 nicotinic receptor antagonists act at different sites.

Authors:  Michael Ellison; J Michael McIntosh; Baldomero M Olivera
Journal:  J Biol Chem       Date:  2002-10-15       Impact factor: 5.157

8.  SLURP-2, a novel member of the human Ly-6 superfamily that is up-regulated in psoriasis vulgaris.

Authors:  Hitomi Tsuji; Koichi Okamoto; Yasunari Matsuzaka; Hajime Iizuka; Gen Tamiya; Hidetoshi Inoko
Journal:  Genomics       Date:  2003-01       Impact factor: 5.736

9.  Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda.

Authors:  Fabrice Chimienti; Ronald C Hogg; Laure Plantard; Caroline Lehmann; Noureddine Brakch; Judith Fischer; Marcel Huber; Daniel Bertrand; Daniel Hohl
Journal:  Hum Mol Genet       Date:  2003-09-23       Impact factor: 6.150

10.  Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures.

Authors:  Patrick H N Celie; Sarah E van Rossum-Fikkert; Willem J van Dijk; Katjusa Brejc; August B Smit; Titia K Sixma
Journal:  Neuron       Date:  2004-03-25       Impact factor: 17.173

View more
  40 in total

1.  Mechanisms of inhibition and potentiation of α4β2 nicotinic acetylcholine receptors by members of the Ly6 protein family.

Authors:  Meilin Wu; Clare A Puddifoot; Palmer Taylor; William J Joiner
Journal:  J Biol Chem       Date:  2015-08-14       Impact factor: 5.157

2.  Structural Insight into Specificity of Interactions between Nonconventional Three-finger Weak Toxin from Naja kaouthia (WTX) and Muscarinic Acetylcholine Receptors.

Authors:  Ekaterina N Lyukmanova; Zakhar O Shenkarev; Mikhail A Shulepko; Alexander S Paramonov; Anton O Chugunov; Helena Janickova; Eva Dolejsi; Vladimir Dolezal; Yuri N Utkin; Victor I Tsetlin; Alexander S Arseniev; Roman G Efremov; Dmitry A Dolgikh; Mikhail P Kirpichnikov
Journal:  J Biol Chem       Date:  2015-08-04       Impact factor: 5.157

3.  Ly6h regulates trafficking of alpha7 nicotinic acetylcholine receptors and nicotine-induced potentiation of glutamatergic signaling.

Authors:  Clare A Puddifoot; Meilin Wu; Rou-Jia Sung; William J Joiner
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

4.  Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development.

Authors:  Katarzyna Lubecka; Kirsty Flower; Megan Beetch; Jay Qiu; Lucinda Kurzava; Hannah Buvala; Adam Ruhayel; Samer Gawrieh; Suthat Liangpunsakul; Tracy Gonzalez; George McCabe; Naga Chalasani; James M Flanagan; Barbara Stefanska
Journal:  Epigenetics       Date:  2018-07-30       Impact factor: 4.528

Review 5.  Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses.

Authors:  Julie M Miwa; Robert Freedman; Henry A Lester
Journal:  Neuron       Date:  2011-04-14       Impact factor: 17.173

6.  Interaction of three-finger proteins from snake venoms and from mammalian brain with the cys-loop receptors and their models.

Authors:  G Faure; I V Shelukhina; D Porowinska; M A Shulepko; E N Lyukmanova; D A Dolgikh; E N Spirova; I E Kasheverov; Yu N Utkin; J-P Corringer; V I Tsetlin
Journal:  Dokl Biochem Biophys       Date:  2016-07-15       Impact factor: 0.788

7.  SLEEPLESS is a bifunctional regulator of excitability and cholinergic synaptic transmission.

Authors:  Meilin Wu; James E Robinson; William J Joiner
Journal:  Curr Biol       Date:  2014-03-06       Impact factor: 10.834

8.  Isoform-specific mechanisms of α3β4*-nicotinic acetylcholine receptor modulation by the prototoxin lynx1.

Authors:  Andrew A George; Abigail Bloy; Julie M Miwa; Jon M Lindstrom; Ronald J Lukas; Paul Whiteaker
Journal:  FASEB J       Date:  2017-01-18       Impact factor: 5.191

9.  GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.

Authors:  Anne P Beigneux; Loren G Fong; André Bensadoun; Brandon S J Davies; Monika Oberer; Henrik Gårdsvoll; Michael Ploug; Stephen G Young
Journal:  Circ Res       Date:  2014-11-11       Impact factor: 17.367

10.  Water-soluble LYNX1 residues important for interaction with muscle-type and/or neuronal nicotinic receptors.

Authors:  Ekaterina N Lyukmanova; Mikhail A Shulepko; Svetlana L Buldakova; Igor E Kasheverov; Zakhar O Shenkarev; Roman V Reshetnikov; Sergey Y Filkin; Denis S Kudryavtsev; Lucy O Ojomoko; Elena V Kryukova; Dmitry A Dolgikh; Mikhail P Kirpichnikov; Piotr D Bregestovski; Victor I Tsetlin
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.